The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLC.
JTO Clin Res Rep
; 3(8): 100373, 2022 Aug.
Article
in En
| MEDLINE
| ID: mdl-35941997
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
JTO Clin Res Rep
Year:
2022
Document type:
Article
Affiliation country:
Japón
Country of publication:
Estados Unidos